Impressive example of parameter estimation enabling prediction of responses of various cancer cell lines was presented by Frohlich et al.72, who integrated RAS/MAPK and AKT signaling pathways into model accounting for more than 100 genes and 36 activating mutations yielding a total of 1,228 molecular species. This evidence concerns the gene AKT1 and cancer.